Dentalkart’s Q2 FY26 concall felt less like an earnings discussion and more like a TED Talk on patience. Growth slowed, margins compressed, inventory ballooned—and management didn’t dodge a single punch. Instead, they leaned in and said: this was intentional.
While most founders chase quarterly dopamine, Dentalkart chose warehouse chaos, tech revamps, SKU overload, and slower revenue. All in the name of a 10-year vision. Doctors still want faster deliveries, investors still want faster growth, and the company is stuck pleasing both—simultaneously.
Half the sales now come from in-house brands. Offline still matters. Inventory days are unapologetically high. And EBITDA? Temporarily sacrificed at the altar of “building the engine.”
Read on—because beneath the calm confidence lies a high-stakes bet on scale, speed, and dentist loyalty.
2. At a Glance
Revenue growth slowed – Management says this was “by design,” not demand fatigue.
Inventory surged – Stockouts are unacceptable; balance sheet discipline took a backseat.
~50% sales from own brands – Private labels quietly running the show.
EBITDA margins compressed – Warehouses, tech, and hiring ate first; profits will eat later.
Equipment mix up – Not strategy, just where momentum showed up.
No major FY27 capex planned – The spending hangover phase begins.
3. Management’s Key Commentary
“Slower growth is not due to demand or competition.” (Translation: We chose pain over panic 😏)
“We expanded warehouses, inventory, SKUs, tech, teams—everything at once.” (Translation: Yes, we broke a few things.)
“Inventory represents trust for dentists.” (Translation: Empty shelves kill loyalty faster than low margins.)
“Inventory days may stay at 120–150 in the short term.” (Translation: Don’t expect Nykaa-style efficiency… yet.)
“EBITDA margins should return to mid-teens over time.” (Translation: This margin dip is a feature, not a bug.)
“Around half our sales now come from own brands.” (Translation: Gross margin cushion is real.)
“This year is about building the engine.” (Translation: Acceleration postponed, not cancelled 🚗)
4. Numbers Decoded
Metric
Commentary
Revenue Growth
Slower YoY, intentionally throttled
Own Brand Mix
~50% of sales
Inventory Days
120–150 (short term), <100 (long term hope)
EBITDA Margin
Compressed due to infra + people costs
Equipment Share
Up in recent quarters
Capex FY27
No major plans announced
Growth was sacrificed for system stability.
Inventory is a strategic weapon, not an accident.
Margins are paying for future operating leverage.
5. Analyst Questions (Decoded)
Why so much inventory when growth is slow? Answer: Availability > efficiency, at this stage.
